ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CTY vs SPTX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

City Therapeutics Inc. (NASDAQ) VS. Seaport Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CTY 1 — SPTX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTY VS. SPTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CTY SPTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality — — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.6 48.7 +12.93 CTY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.11B $1.13B -$15.1M SPTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CTY REV SPTX REV CTY GROSS % SPTX GROSS % CTY FCF SPTX FCF
FY 2025 — $0 — — — —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTY // BETA —
SPTX // BETA —